Edition:
United Kingdom

People: GW Pharmaceuticals PLC (GWPH.OQ)

GWPH.OQ on NASDAQ Stock Exchange Global Market

151.01USD
21 Jun 2018
Change (% chg)

$-1.52 (-1.00%)
Prev Close
$152.53
Open
$154.76
Day's High
$155.60
Day's Low
$150.74
Volume
73,097
Avg. Vol
101,427
52-wk High
$164.58
52-wk Low
$95.65

Gover, Justin 

Mr. Justin Gover is Chief Executive Officer, Director of GW Pharmaceuticals PLC. He has 17 years' experience in the pharmaceutical industry. As Chief Executive Officer, he has been the lead executive responsible for the running of our company's operations, as well as in leading equity financings and business development activities. Prior to joining our company, Mr. Gover was Head of Corporate Affairs at Ethical Holdings plc from 1995 to 1997 where he was responsible for the company's strategic corporate activities, including mergers and acquisitions, strategic investments, equity financings and investor relations. Mr. Gover holds an M.B.A. from INSEAD and a BSc. (Hons) from Bristol University.

Basic Compensation

Total Annual Compensation, USD 297,910
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD 774,582
All Other, USD 317,743
Fiscal Year Total, USD 1,390,240

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Geoffrey Guy

1,695,890

Justin Gover

1,390,240

James Noble

61,984

Adam George

749,989

Christopher Tovey

460,735

Julian Gangolli

--
As Of  30 Sep 2014